慢性硬膜下血肿:矛盾优势征预测脑膜中动脉外侧支供血
本研究回顾性分析125例接受脑膜中动脉栓塞的慢性硬膜下血肿患者,提出「矛盾优势征」(对侧脑膜中动脉直径大于同侧≥0.2 mm)。该征象患者侧支供血发生率显著高于同侧优势组(93.75% vs 35.78%,p<0.001)。同侧脑膜中动脉直径≤1.384 mm可预测存在附加侧支(p<0.001)。
要点
- 矛盾优势征提示慢性硬膜下血肿存在附加侧支供血,应全面评估血肿膜动脉来源。
- 同侧脑膜中动脉直径≤1.384 mm时警惕存在脑膜中动脉以外的侧支供血。
- 识别并栓塞附加侧支后,矛盾优势征组与同侧优势组临床结局相当。
核心结论
- 慢性硬膜下血肿的供血来源具有异质性,附加侧支是脑膜中动脉栓塞后复发的重要原因之一。
- 矛盾优势征是识别慢性硬膜下血肿附加侧支供血的可靠血流动力学标志。
- 评估双侧脑膜中动脉相对不对称性而非绝对直径,可实现对患者的简便分层。
研究设计与样本
- 矛盾优势征定义为对侧脑膜中动脉直径大于同侧≥0.2 mm。
- 研究比较矛盾优势征组与同侧优势组的侧支供血模式和临床结局。
关键影像表现/征象
- 矛盾优势征表现为对侧脑膜中动脉管径大于同侧脑膜中动脉,相差≥0.2 mm。
- 矛盾优势征组存在附加侧支供血的比例为93.75%,同侧优势组为35.78%。
- 矛盾优势征组更可能同时存在多个侧支供血来源(p<0.001)。
- 同侧优势组中,同侧脑膜中动脉直径≤1.462 mm提示侧支供血风险显著增高(53.70% vs 18.18%,p<0.001)。
诊断标准与关键数值
- 矛盾优势征定义:对侧脑膜中动脉直径超出同侧脑膜中动脉≥0.2 mm。
- 全体队列中,同侧脑膜中动脉直径≤1.384 mm可预测存在附加侧支(p<0.001)。
- 同侧优势组中,同侧脑膜中动脉直径≤1.462 mm提示侧支供血风险显著增高(p<0.001)。
- 矛盾优势征组侧支供血发生率为93.75%,同侧优势组为35.78%(p<0.001)。
临床应用与阅片要点
- 报告慢性硬膜下血肿介入术前血管评估时,应测量并比较双侧脑膜中动脉直径。
- 发现矛盾优势征时应提示临床存在附加侧支供血的可能,建议全面评估血肿膜动脉来源。
- 识别矛盾优势征有助于指导对血肿膜动脉进行更全面的栓塞,降低栓塞后复发风险。
局限性
- 单中心回顾性研究设计,结论的普遍适用性尚未证实。
- 同侧脑膜中动脉直径≤1.384 mm与侧支的相关性支持既往假说,但外推性未经证实。
- 样本中矛盾优势征仅16例(12.8%),该亚组分析结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Middle meningeal artery embolization (MMAE) is an emerging treatment for chronic subdural hematoma (CSDH). However, hematoma recurrence remains a challenge, often due to collateral vascular supply from heterogenous sources. We aimed to explore the correlation between small MMA and collaterals, and identified a distinct angiographic phenomenon termed the "paradoxical predominance sign" where the contralateral MMA is larger than the ipsilateral MMA and hypothesized that this sign predicts the presence of collateral supply.
MATERIALS AND METHODS: We performed a retrospective analysis of 125 patients with CSDH who underwent embolization at our center between October 2022 and August 2025. Patients were categorized based on the paradoxical predominance sign defined as a contralateral MMA diameter exceeding the ipsilateral MMA by ≥ 0.2 mm. We investigated the concordance between MMA diameter and the presence of contributing collaterals, comparing supply patterns between patients with typical ipsilateral predominance and those exhibiting the paradoxical sign.
RESULTS: In the general cohort, a smaller ipsilateral MMA (≤ 1.384 mm) was predictive of additional collaterals (p < 0.001). The paradoxical predominance sign was identified in 16 patients (12.8%). Patients in this group exhibited a significantly higher prevalence of contributing collaterals compared to the ipsilateral predominance group (93.75% vs. 35.78%; p < 0.001) and were more likely to have multiple collateral sources (p < 0.001). Furthermore, within the ipsilateral predominance group, a diameter of ipsilateral MMA ≤ 1.462 mm indicated a significantly higher risk of collateral supply (53.70% vs. 18.18%; p < 0.001). Clinical outcomes, including recurrence and hematoma resorption, were comparable between groups, suggesting that successful embolization of identified collaterals neutralized the risk.
CONCLUSIONS: The hematoma membrane arterial supply in CSDH is heterogeneous, with additional collaterals contributing to MMAE recurrence risk. An ipsilateral MMA diameter ≤1.384 mm correlates with more collaterals, supporting prior hypotheses but with unproven generalizability. The paradoxical predominance sign is a robust hemodynamic biomarker for identifying additional collaterals. Assessing relative MMA asymmetry instead of absolute diameters enables simple patient stratification, and recognition of this sign guides comprehensive hematoma membrane arterial embolization, thereby improving endovascular treatment efficacy for CSDH.
引用
- Li, Jiang, Xia, et al. Beyond Middle Meningeal Artery: Paradoxical Predominance Sign Predicts Additional Collaterals Supplying Chronic Subdural Hematoma. AJNR Am J Neuroradiol. 2026. PMID: 42586762. doi:10.3174/ajnr.A9585
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。